Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12605000033640
Ethics application status
Approved
Date submitted
19/07/2005
Date registered
22/07/2005
Date last updated
3/07/2009
Type of registration
Prospectively registered
Titles & IDs
Public title
Comparitive Rehydration in Bronchiolitis
Query!
Scientific title
A prospective randomized trial comparing nasogastric with intravenous rehydration in children with bronchiolitis
Query!
Secondary ID [1]
912
0
Comparitive Rehydration in Bronchiolitis
Query!
Secondary ID [2]
913
0
Comparitive Rehydration in Bronchiolitis
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
CRIB
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Bronchiolitis
96
0
Query!
Condition category
Condition code
Respiratory
117
117
0
0
Query!
Other respiratory disorders / diseases
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Open randomised trial comparing nasogastric and intravenous hydration in children under 1 year of age with bronchiolitis.
Query!
Intervention code [1]
40
0
Treatment: Other
Query!
Comparator / control treatment
intravenous versus nasogastric route for hydration. each intervention is a one off, for fluid administration. Intravenous drip (IV) insertion is using topical anaesthesia and site is at the discretion of the clinician. Nasogastric insertion is using topical anaesthetic sprar and in either nostril. Standardised means of determining insertion are used. Fluid administration is 80% maintnance with 0.9% sodium chloride with 5% dextrose in the IV goup and oral rehydration solution for the first 2 hours then usual feed for the nasogastric group
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
147
0
Length of inpatient length of stay
Query!
Assessment method [1]
147
0
Query!
Timepoint [1]
147
0
time till discharge in days - kept electronically and measured continuously until discharge
Query!
Secondary outcome [1]
322
0
1 To assess the duration of oxygen therapy in each group.
Query!
Assessment method [1]
322
0
Query!
Timepoint [1]
322
0
time of oxygen treatment in days - recorded 3 times per day until discharge
Query!
Secondary outcome [2]
323
0
2 To assess the duration of NR and IR.
Query!
Assessment method [2]
323
0
Query!
Timepoint [2]
323
0
time of non oral hydration in days - recorded 3 times per day until discharge
Query!
Secondary outcome [3]
324
0
3 To assess the length of inpatient stay in patients treated with NR and IR.
Query!
Assessment method [3]
324
0
Query!
Timepoint [3]
324
0
time until discharge - recorded continuously until discharge
Query!
Secondary outcome [4]
325
0
4 To document the incidence of patient deterioration with different hydration strategies in bronchiolitis, defined by forced change from NR to IR, need of ventilatory support, and ICU admission.
Query!
Assessment method [4]
325
0
Query!
Timepoint [4]
325
0
measured 3 times daily until discharge
Query!
Secondary outcome [5]
326
0
5 To document the incidence of complications of rehydration therapy (e.g. electrolyte abnormalities, iv line/NGT needing replacement because of blockage or loss, iv tissuing, aspiration).
Query!
Assessment method [5]
326
0
Query!
Timepoint [5]
326
0
measured 3 times per day until discharge
Query!
Secondary outcome [6]
327
0
6 To assess the parents satisfaction with NR and IR.
Query!
Assessment method [6]
327
0
Query!
Timepoint [6]
327
0
Daily during inpatient stay, and at time of discharge
Query!
Eligibility
Key inclusion criteria
1 Age more than 8 weeks (corrected for prematurity) and less than 12 months. 2 With symptoms of bronchiolitis as defined by respiratory distress (tachypnoea, recessions, nasal flaring etc.) due to acute viral respiratory tract infection. 3 Requiring hydration.
Query!
Minimum age
8
Weeks
Query!
Query!
Maximum age
12
Months
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
1 Chronic respiratory disease. 2 Choanal atresia. 3 Severe dehydration (needing iv resuscitation). 4 Need of immediate ventilatory support. 5 Increased respiratory effort (severe recessions) and hypoxaemia (SaO2 <90% in >30% FiO2, or >2l/min O2). 6 Reasons for needing iv access other than bronchiolitis (investigations, medication).
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
opaque envelope opened after consent at time of institution of hydration. Sequence concealed until randomisation
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Computer generated random block assignment
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Single group
Query!
Other design features
Query!
Phase
Query!
Type of endpoint/s
Safety/efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
1/05/2009
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
750
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Funding & Sponsors
Funding source category [1]
162
0
Government body
Query!
Name [1]
162
0
NHMRC
Query!
Address [1]
162
0
16 Marcus Clarke Street
Canberra ACT 2601
Query!
Country [1]
162
0
Australia
Query!
Primary sponsor type
Government body
Query!
Name
National Health and Medical Research Council
Query!
Address
16 Marcus Clarke Street
Canberra ACT 2601
Query!
Country
Australia
Query!
Secondary sponsor category [1]
117
0
None
Query!
Name [1]
117
0
Nil
Query!
Address [1]
117
0
Query!
Country [1]
117
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
907
0
RCH Melbourne
Query!
Ethics committee address [1]
907
0
Query!
Ethics committee country [1]
907
0
Australia
Query!
Date submitted for ethics approval [1]
907
0
Query!
Approval date [1]
907
0
Query!
Ethics approval number [1]
907
0
Query!
Summary
Brief summary
The need for supplying fluids in paediatric bronchiolitis (severe viral airway infection of the infant) is frequent, and is the consequence of reduced feeding, sweating, and fever., There are currently 2 means of supplying fluids, intravenous or nasogastric. Nasogastric rehydration (NR) means giving fluids through a feeding tube inserted through the nostrils into the stomach thus eliminating the effort of drinking. It is generally effective and has few complications. Intra venous rehydration (IR) means giving fluids directly into a vein through a drip. It is often difficult to insert a drip in this particular age group, whereas the nasal feeding tube is generally easier to insert. The potential complications of IR are water overload and electrolyte imbalances. The main possible complications of NR is vomiting. The role of NR in bronchiolitis is, however, controversial. It is, for example, an accepted treatment in Scandinavia and Switzerland, whereas IR is the accepted treatment at the RCH Melbourne. Even within Australia there is no standard of care as such among the different hospitals with most hospitals using a combination of NR and IR, without any guidelines. The little existing evidence shows that NR in bronchiolitis is safe and well tolerated. The major concern raised with NR is the partial obstruction of the airway, by cousing ablockage of the nostril in young children who mostly breathe through the nose, thus theoretically causing further breathing problems. But its clinical significance, especially in bronchiolitis, is not clear and has not been the subject of clinical trials. In this prospective study we will compare Nasogastric and Intravenous treatment in bronchiolitis.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
35645
0
Query!
Address
35645
0
Query!
Country
35645
0
Query!
Phone
35645
0
Query!
Fax
35645
0
Query!
Email
35645
0
Query!
Contact person for public queries
Name
9229
0
Ed Oakley
Query!
Address
9229
0
Department of Emergrncy Medicnie monash Medical Clayton 246 Centre Road Clayton 3168
Query!
Country
9229
0
Australia
Query!
Phone
9229
0
+61 3 95942707
Query!
Fax
9229
0
+61 3 95946564
Query!
Email
9229
0
[email protected]
Query!
Contact person for scientific queries
Name
157
0
Ed Oakley
Query!
Address
157
0
Department of Emergrncy Medicnie monash Medical Clayton 246 Centre Road Clayton 3168
Query!
Country
157
0
Australia
Query!
Phone
157
0
+61 3 95942707
Query!
Fax
157
0
+61 3 95946564
Query!
Email
157
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Economic evaluation of nasogastric versus intravenous hydration in infants with bronchiolitis.
2017
https://dx.doi.org/10.1111/1742-6723.12713
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF